从MedDRA分类推导常见合并症指数并探索其在类风湿关节炎患者关键结局中的表现
研究开发了从MedDRA分类计算风湿病合并症指数(RDCI)、Charlson-Deyo指数(CDI)和功能合并症指数(FCI)的算法,并在4126例类风湿关节炎患者中评估这些指数对临床结局、效用和健康资源利用的预测价值。所有合并症指数均与各结局相关,RDCI和FCI在临床结局上表现较好,CDI在预测功能与健康相关结局时表现稍差。
要点
- 已建立从MedDRA分类计算RDCI、CDI和FCI的算法。
- 在4126例类风湿关节炎患者中,各合并症指数均与结局相关,性能差异中等。
- RDCI和FCI在预测临床结局方面表现更好,CDI在预测功能与健康结局时稍差。
核心结论
- 现已可用算法从MedDRA分类计算三种常用合并症指数,各指数预测多种结局的表现相当,CDI在预测反映功能与健康的结局时表现稍差。
研究设计与样本
- 两名独立研究者将MedDRA分类的优选术语映射到RDCI、CDI和FCI所包含的疾病中。
- 利用挪威Register-DMARD研究(接受DMARD治疗的炎性关节病患者登记研究)的数据,在调整年龄、性别和DAS28的模型中研究这些指数的解释价值。
- 采用广义估计方程模型比较模型拟合统计量,结局包括修改版HAQ、HAQ、SF-36躯体与心理成分总结、SF6D和非RA相关健康资源利用。
主要发现
- 共纳入4126例RA患者,女性占72%,平均(标准差)年龄56(14)岁。
- 基线时RDCI中位数(四分位距)为0.0(1.0)[范围0-6],CDI为0.0(0.0)[0-7],FCI为0.0(1.0)[0-6]。
- 所有合并症指数均与每一结局相关,各指数间性能差异中等。
- RDCI和FCI在修改版HAQ和HAQ、住院、躯体与心理成分总结及SF6D等临床结局上表现更好。
- 任何非RA相关健康资源利用的最佳预测指标为RDCI,其次为CDI。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop algorithms for calculating the Rheumatic Diseases Comorbidity Index (RDCI), Charlson-Deyo Index (CDI) and Functional Comorbidity Index (FCI) from the Medical Dictionary for Regulatory Activities (MedDRA), and to assess how these MedDRA-derived indices predict clinical outcomes, utility and health resource utilization (HRU). METHODS: Two independent researchers linked the preferred terms of the MedDRA classification into the conditions included in the RDCI, the CDI and the FCI. Next, using data from the Norwegian Register-DMARD study (a register of patients with inflammatory joint diseases treated with DMARDs), the explanatory value of these indices was studied in models adjusted for age, gender and DAS28. Model fit statistics were compared in generalized estimating equation (prediction of outcome over time) models using as outcomes: modified HAQ, HAQ, physical and mental component summary of SF-36, SF6D and non-RA related HRU. RESULTS: Among 4126 patients with RA [72% female, mean (s.d.) age 56 (14) years], median (interquartile range) of RDCI at baseline was 0.0 (1.0) [range 0-6], CDI 0.0 (0.0) [0-7] and FCI 0.0 (1.0) [0-6]. All the comorbidity indices were associated with each outcome, and differences in their performance were moderate. The RDCI and FCI performed better on clinical outcomes: modified HAQ and HAQ, hospitalization, physical and mental component summary, and SF6D. Any non-RA related HRU was best predicted by RDCI followed by CDI. CONCLUSION: An algorithm is now available to compute three commonly used comorbidity indices from MedDRA classification. Indices performed comparably well in predicting a variety of outcomes, with the CDI performing slightly worse when predicting outcomes reflecting functioning and health.
引用
- Putrik P, Ramiro S, Lie E, et al. Deriving common comorbidity indices from the MedDRA classification and exploring their performance on key outcomes in patients with rheumatoid arthritis. Rheumatology (Oxford). 2018. PMID: 29272517. doi:10.1093/rheumatology/kex440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。